FRR Shares (Makes you Realise)

Equity

Home/ Are You A Trader/ Market Info/ Company Profile/ Smart Quotes

COMPANY PROFILE

SHILPA MEDICARE LTD.

NSE : SHILPAMEDBSE : 530549ISIN CODE : INE790G01031Industry : Pharmaceuticals & DrugsHouse : Private

BSE781.5046.5 (+6.33 %)

PREV CLOSE (Rs.) 735.00

OPEN PRICE (Rs.) 740.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 26314

TODAY'S LOW / HIGH (Rs.)722.85 802.15

52 WK LOW / HIGH (Rs.)419.1 959.95

NSE783.3547.75 (+6.49 %)

PREV CLOSE( Rs. ) 735.60

OPEN PRICE (Rs.) 743.00

BID PRICE (QTY) 783.35 (10591)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 946898

TODAY'S LOW / HIGH(Rs.) 723.00 804.40

52 WK LOW / HIGH (Rs.)417.6 959.5

More From Company Profile

Smart Quotes

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Trade Value (Rs. in Lacs)

200.71

Dividend Yield(%)

0.00

TTM EPS (Rs.)

8.66

P/E Ratio

90.23

Book Value (Rs.)

276.89

Face Value (Rs.)

MCap (Rs. in Mn)

76423.59

Price/Earning (TTM)

57.25

Price/Sales (TTM)

17.42

Price/Book (MRQ)

2.82

PAT Margin (%)

8.70

ROCE (%)

2.36

Incorporation Year : 1987

Management Info :

Omprakash Inani - Chairman Vishnukant Bhutada - Managing Director

Registered Office :

Address : Shilpa House,#12-6-214/ A1,Hyderabad Road,
Raichur,
Karnataka-584135

Phone : 08532-238704

Email : info@vbshilpa.com

Website : www.vbshilpa.com

Registrars Details :

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

23May Shilpa Medicare’s arm enters into stra
Shilpa Medicare’s 100% subsidiary -- Shilpa Biocare has entered into a s..

15May USFDA issues EIR to unit-1 of Shilpa M
The United States Food and Drugs Administration (USFDA) has issued Estab..

15May Shilpa Medicare surges on the BSE
Shilpa Medicare is currently trading at Rs 706.95, up by 12.80 points or..

Financials

	QTR Dec 24	ANNUAL 24
Net Profit	161.22	269.37
Gross Profit	253.32	380.89
Operating Profit	393.89	1154.08
Net Sales	1253.87	3097.87

Rs. in Millions

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Emcure Pharma (BSE)

1288.65 (10.00%)

M.Cap (Rs. in Cr)24417.77

Medplus Health Servi (BSE)

950.90 (7.36%)

M.Cap (Rs. in Cr)11381.69

Orchid Pharma (BSE)

754.40 (4.21%)

M.Cap (Rs. in Cr)3826.25

RPG Life Sciences (BSE)

2198.65 (1.36%)

M.Cap (Rs. in Cr)3636.35

Shareholding Pattern

	PROMOTERS	44.23%
	NON-INSTITUTION	37.25%
	MUTUAL FUNDS/UTI	4.05%
	FI/BANKS/INSURANCE	2.08%
	GOVERNMENT	0%
	FII	0%

Mf Holding

Scheme Name

Hold(%)

ICICI Pru Pharma He...

1.30

Bandhan Innovation ...

1.15

ITI Pharma & Health...

1.02

Bandhan Small Cap F...

0.82

WOC Special Opp Fun...

0.56

Motilal Oswal Nifty...

0.54

ICICI Pru ELSS Tax ...

0.50

Attention Investors

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month, Issued in the interest of Investors.

Risk Disclosure on Derivatives | Smart ODR | Mandatory Display | KYC Validation Links

BSE / NSE SEBI Registration No. INZ000279232, Depository Participant SEBI Registration No. – IN DP CDSL 132-2015

Mutual funds - ARN No. 81648 , Investment Adviser SEBI Registration No. : INA000008668.

CLOSE X

Risk Disclosures On Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22

SHILPA MEDICARE LTD.

Smart Quotes

Attention Investors

Download Client Registration Documents

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language :

Filing complaints on SCORESEasy & quick

Risk Disclosures On Derivatives